文献速递胃肠外科

淋巴结阳性胃癌的淋巴结检出数与淋巴结比率基准

Benchmarks for nodal yield and ratio for node-positive gastric cancer.
PubMed 文献 · Surgery · 2021-05-28

该研究基于MD Anderson癌症中心1995-2019年收治的281例非转移性淋巴结阳性胃癌患者,分析根治性胃切除术后淋巴结检出数和淋巴结比率与预后的关系。结果显示检出淋巴结≥30枚和淋巴结比率<30%与更长的无复发生存和总生存独立相关,pN3与更差生存相关。

要点

  • 淋巴结阳性胃癌中检出淋巴结≥30枚与更好生存独立相关。
  • 淋巴结比率<30%与更长的无复发生存和总生存独立相关。
  • pN3类别与更差的总生存和无复发生存相关。

核心结论

  • 检出淋巴结≥30枚和淋巴结比率<30%与更长的无复发生存和总生存显著相关,且独立于淋巴结清扫类型。

研究设计与样本

  • 回顾性队列研究,纳入1995-2019年在MD Anderson癌症中心接受根治性胃切除术的非转移性淋巴结阳性胃癌患者,775例中281例符合纳入标准。

主要发现

  • 281例患者平均年龄58岁,61%为男性,51%为白人,65%接受术前治疗,71%肿瘤位于胃体。
  • 中位总生存为3.6年,1年、5年和10年总生存率分别为91%、41%和29%。
  • 淋巴结负荷与原发性肿瘤的侵袭性生物学特征相关,包括更高的淋巴血管和神经周围侵犯率及更低的术前治疗反应率。
  • 调整分析中,阳性切缘、联合器官切除、检出淋巴结<30枚和淋巴结比率≥30%与更差的无复发生存和总生存相关。

关键数值与推荐

  • 受试者操作特征分析显示,检出淋巴结≥30枚和淋巴结比率<30%对总生存的判别最具区分度。
  • 调整分析显示,检出淋巴结<30枚和淋巴结比率≥30%与更差的无复发生存和总生存相关。

临床怎么用

  • 在美国胃癌手术管理中,应考虑将检出淋巴结≥30枚和淋巴结比率<30%作为预后基准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We aimed to elucidate prognostic markers of node-positive gastric cancers with a focus on examined lymph nodes and lymph node ratio. METHODS: Patients treated with curative-intent gastrectomy at The University of Texas MD Anderson Cancer Center from 1995-2019 were evaluated. Patients with non-metastatic, node-positive gastric cancers were considered for analysis. RESULTS: Of 775 patients, 281 met the inclusion criteria. The mean age was 58 years, 61% were male, 51% were White, 65% received preoperative therapy, and 71% of tumors were located in the gastric body. The median overall survival was 3.6 years, and 1-, 5-, and 10-year overall survival rates were 91%, 41%, and 29%, respectively. pN3 category was associated with worse overall survival (hazard ratio 1.79, P = .001) and recurrence-free survival (hazard ratio 1.92, P = .004). Nodal burden was associated with aggressive biologic traits in primary tumors, including higher rates of lymphovascular and perineural invasion and lower preoperative therapy response rates. By receiver-operative characteristic analysis, threshold values of ≥30 examined lymph nodes and <30% lymph node ratio were most discriminant for overall survival. On adjusted analysis, positive margins, additional organ resection, <30 examined lymph nodes, and ≥30% lymph node ratio were associated with worse recurrence-free survival and overall survival. Among patients with high node burden (pN3), <30 examined lymph nodes remained significant on adjusted survival analysis. CONCLUSION: Greater than or equal to 30 examined lymph nodes and <30% lymph node ratio were significantly associated with longer recurrence-free survival and overall survival, independent of lymphadenectomy type. These prognostic benchmarks should be considered in the surgical management of gastric cancer in the United States.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Erstad DJ, Blum M, Estrella JS, et al. Benchmarks for nodal yield and ratio for node-positive gastric cancer. Surgery. 2021. PMID: 34059344. doi:10.1016/j.surg.2021.04.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。